These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31268175)

  • 21. The global epidemic of obesity: are we becoming more sympathetic?
    Davy KP
    Curr Hypertens Rep; 2004 Jun; 6(3):241-6. PubMed ID: 15128479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural mechanisms in human obesity-related hypertension.
    Rumantir MS; Vaz M; Jennings GL; Collier G; Kaye DM; Seals DR; Wiesner GH; Brunner-La Rocca HP; Esler MD
    J Hypertens; 1999 Aug; 17(8):1125-33. PubMed ID: 10466468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.
    Straznicky NE; Lambert EA; Lambert GW; Masuo K; Esler MD; Nestel PJ
    J Clin Endocrinol Metab; 2005 Nov; 90(11):5998-6005. PubMed ID: 16091482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sympathetic activation in obese normotensive subjects.
    Grassi G; Seravalle G; Cattaneo BM; Bolla GB; Lanfranchi A; Colombo M; Giannattasio C; Brunani A; Cavagnini F; Mancia G
    Hypertension; 1995 Apr; 25(4 Pt 1):560-3. PubMed ID: 7721398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenergic nervous system in heart failure.
    Esler M; Kaye D; Lambert G; Esler D; Jennings G
    Am J Cardiol; 1997 Dec; 80(11A):7L-14L. PubMed ID: 9412538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G
    Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sympathetic nervous system behavior in human obesity.
    Davy KP; Orr JS
    Neurosci Biobehav Rev; 2009 Feb; 33(2):116-24. PubMed ID: 18602694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sympathetic system and hypertension.
    Esler M
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):99S-105S. PubMed ID: 10921528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sympathetic nervous system and obesity: role in aetiology and treatment.
    Snitker S; Macdonald I; Ravussin E; Astrup A
    Obes Rev; 2000 May; 1(1):5-15. PubMed ID: 12119646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).
    Landsberg L
    J Hypertens; 2001 Mar; 19(3 Pt 2):523-8. PubMed ID: 11327624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.
    Ernsberger P; Koletsky RJ; Collins LA; Bedol D
    Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():275-82. PubMed ID: 8827950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced adipose afferent reflex contributes to sympathetic activation in diet-induced obesity hypertension.
    Xiong XQ; Chen WW; Han Y; Zhou YB; Zhang F; Gao XY; Zhu GQ
    Hypertension; 2012 Nov; 60(5):1280-6. PubMed ID: 23033372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome: a sympathetic disease?
    Schlaich M; Straznicky N; Lambert E; Lambert G
    Lancet Diabetes Endocrinol; 2015 Feb; 3(2):148-57. PubMed ID: 24731670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex differences in sympathetic activity in obesity and its related hypertension.
    Fu Q
    Ann N Y Acad Sci; 2019 Oct; 1454(1):31-41. PubMed ID: 31087350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sympathetic nerves and hypertension in stress, sleep apnea, and caregiving.
    Ziegler MG; Milic M
    Curr Opin Nephrol Hypertens; 2017 Jan; 26(1):26-30. PubMed ID: 27755119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympathetic Neural Overdrive in the Obese and Overweight State.
    Grassi G; Biffi A; Seravalle G; Trevano FQ; Dell'Oro R; Corrao G; Mancia G
    Hypertension; 2019 Aug; 74(2):349-358. PubMed ID: 31203727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980.
    Young JB; Macdonald IA
    Int J Obes Relat Metab Disord; 1992 Dec; 16(12):959-67. PubMed ID: 1335975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.
    Esler M
    J Appl Physiol (1985); 2010 Feb; 108(2):227-37. PubMed ID: 19940096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.